Vascular response to angiotensin II in upper body obesity

Hypertension

Volumn 44, Issue 4, 2004, Pages 435-441

  Nielsen, Søren ^a   Halliwill, John R ^a   Joyner, Michael J ^a   Jensen, Michael D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Blood flow; Fatty acids

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; CATECHOLAMINE; ENDOTHELIUM DERIVED RELAXING FACTOR; FATTY ACID; GLUCOSE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PALMITIC ACID; TRIACYLGLYCEROL;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; BODY COMPOSITION; BODY FAT; BRACHIAL ARTERY; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY EXPENDITURE; FAMILY HISTORY; FATTY ACID METABOLISM; FOREARM BLOOD FLOW; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPOLYSIS; MALE; OBESITY; PRIORITY JOURNAL; SUBCUTANEOUS FAT; VASCULAR RESISTANCE; VASOCONSTRICTION;

ACETYLCHOLINE; ADULT; ANGIOTENSIN II; BLOOD GLUCOSE; BODY COMPOSITION; DOSE-RESPONSE RELATIONSHIP, DRUG; FOREARM; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LIPOLYSIS; MALE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; OBESITY; OMEGA-N-METHYLARGININE; PALMITIC ACID; REGIONAL BLOOD FLOW; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 4644242119     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000142111.67601.6b     Document Type: Article

References (36)

1. Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003;41:625-633.
2. Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens. 2001;19:523-528.
3. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94:1172-1179.
4. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest. 1996;97:2601-2610.
5. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 1993;87:1468-1474.
6. Taddei S, Virdis A, Ghiadoni L, Salvetti A. Vascular effects of endothelin-1 in essential hypertension: relationship with cyclooxygenase-derived endothelium-dependent contracting factors and nitric oxide. J Cardiovasc Pharmacol. 2000;235:S37-S40.
7. Drury PL, Smith GM, Ferriss JB. Increased vasopressor responsiveness to angiotensin II in type 1 (insulin-dependent) diabetic patients without complications. Diabetologia. 1984;24:174-179.
8. Christlieb AR, Janka HU, Kraus B, Gleason RE, Icasas-Cabral EA, Aiello LM, Cabral BV, Solano A. Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes. 1976;25:268-274.
9. Gaboury CL, Simonson DC, Seely EW, Hollenberg NK, Williams GH. Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension. J Clin Invest. 1994;94:2295-2300.
10. Steinberg HO, Baron AD. Vascular function, insulin resistance and fatty acids. Diabetologia. 2004;45:623-634.
11. Egan BM, Hennes MM, Stepniakowski K, O'Shaughnessy IM, Kissebah AH, Goodfriend TL. Obesity hypertension is related more to insulin's fatty acid than glucose action. Hypertension. 1996;27:723-728,
12. Stojiljkovic MP, Zhang D, Lopes HF, Lee CG, Goodfriend TL, Egan BM. Hemodynamic effects of lipids in humans. Am J Physiol Regul Integr Comp Physiol. 2001;280:R1674-R1679.
13. Steinberg HO, Tarshoby M, Monestel R, Hook G, Cronin J, Johnson A, Bayazeed B, Baron AD. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest. 1997;100:1230-1239.
14. Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes. 2000;49:1231-1238.
15. Hirooka Y, Eshima K, Setoguchi S, Kishi T, Egashira K, Takeshita A. Vitamin C improves attenuated angiotensin II-induced endothelium-dependent vasodilation in human forearm vessels. Hypertens Res. 2003;26:953-959.
16. Jensen MD, Kanaley JA, Reed JE, Sheedy PF. Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry. Am J Clin Nutr. 1995;61:274-278.
17. Miles JM, Ellman MG, McClean KL, Jensen MD. Validation of a new method for determination of free fatty acid turnover. Am J Physiol Endocrinol Metab. 1987;252:E431-E438.
18. Jensen MD, Rogers PJ, Ellman MG, Miles JM. Choice of infusion-sampling mode for tracer studies of free fatty acid metabolism. Am J Physiol. 1988;254:E562-E565.
19. Greenfield ADM, Whitney RJ, Mawbray JF. Methods for the investigation of peripheral blood flow. Br Med Bull. 1963;19:101-109.
20. Pawelczyk JA, Levine BD. Limb vascular responsiveness to adrenergic agonists following physical deconditioning. Med Sci Sports Exerc. 1995;27:831.
21. Peiris AN, Sothmann MS, Hoffmann RG, Hennes MI, Wilson CR, Gustafson AB, Kissebah AH. Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med. 1989;110:867-872.
22. Alonso-Galacia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension. 1996;28:1047-1054.
23. Kataoka H, Otsuka F, Ogura T, Yamauchi T, Kishida M, Takahashi M, Mimura Y, Makino H. The role of nitric oxide and the renin-angiotensin system in salt-restricted Dahl rats. Am J Hypertens. 2001;14:276-285.
24. Lyons D, Webster J, Benjamin N. Angiotensin II. Adrenergic sympathetic constrictor action in humans. Circulation. 1995;91:1457-1460.
25. Champion HC, Czapla MA, Kadowitz PJ. Responses to angiotensin peptides are mediated by AT1 receptors in the rat. Am J Physiol. 1998;274:E123.
26. Seidelin PH, collier JG, Struthers AD, Webb DJ. Angiotensin II aguments sympathetically mediated arteriolar constriction in man. Clin Sci (Lond). 1991;81:261-266.
27. Clemson B, Gaul L, Gubin SS, Campsey DM, Mcconville J, Nussberger J, Zelis R. Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm. J Clin Invest. 1994;93:684-691.
28. Taddei S, Virdis A, Mattei P, Favilla S, Salvetti A. Angiotensin II and sympathetic activity in sodium-restricted essential hypertension. Hypertension. 1995;25:595-601.
29. Petrie JR, Ueda S, Webb DJ, Elliott HL, Connell JMC. Endothelial nitric oxide production and insulin sensitivity: a physiological link with implications for pathogenesis of cardiovascular disease. Circulation. 1996;93:1331-1333.
30. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1996;97:22-28.
31. Bergholm R, Vehkavaara S, Tiikkainen M. Obese women are insulin resistant but have normal endothelial function. Diabetologia 2004;44: abstract.
32. Lopes HF, Stojiljkovic MP, Zhang D, Goodfriend TL, Egan BM. The pressor response to acute hyperlipidemia is enhanced in lean normotensive offspring of hypertensive parents. Am J Hypenens. 2001;14:1032-1037.
33. Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker D, Jacob S, Matthaei S, Rett K, Haring HU. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation, 2000;101:1780-1784.
34. Martin ML, Jensen MD. Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest. 1991;88:609-613.
35. Haastrup AT, Stepniakowski KT, Goodfriend TL, Egan BM. Intralipid enhances alpha 1-adrenergic receptor-mediated pressor sensitivity. Hypertension. 1998;32:693-698.
36. Grekin RJ, Vollmer AP, Sider RS. Pressor effects of portal venous oleate infusion. A proposed mechanism for obesity hypertension. Hypertension. 1995;26:193-198.